The quality of care in type 1 and type 2 diabetes – A 2023 update of the AMD Annals Initiative
Russo G, De Cosmo S, Di Bartolo P, et al.
Diabetes Res Clin Pract. Pub. online 13 Jun 2024.
Leggi
How do lifestyle factors modify the association between genetic predisposition and obesity-related phenotypes? A 4-way decomposition analysis using UK Biobank
Zhang M, Ward J, Strawbridge RJ, et al.
BMC Med. Pub. online 10 Jun 2024.
Leggi
Efficacy and tolerability of initial triple combination therapy with metformin, dapagliflozin and saxagliptin compared with stepwise add-on therapy in drug-naïve patients with type 2 diabetes (TRIPLE-AXEL study): A multicentre, randomized, 104-week, open-label, active-controlled trial
Kim NH, Moon JS, Lee YH, et al.
Diabetes Obes Metab. Pub. online 11 Jun 2024.
Leggi
Key results from observational studies and real-world evidence of sodium-glucose cotransporter-2 inhibitor effectiveness and safety in reducing cardio-renal risk
Nyström T
Diabetes Obes Metab. Pub. online 10 Jun 2024.
Leggi
NOVITA’ AMD DIGITAL NETWORK – OCCHIO AL TRIAL
Carissimi Soci, l'offerta formativa AMD digital network si arricchisce con una nuova opportunità per tutti i Soci: "Occhio al trial". In abbinamento alle ormai collaudate dirette scientific talk, è stato ideato questo nuovo spazio di approfondimento scientifico che ci consentirà di analizzare con brevi videopillole i più recenti studi in ambito diabete. Una formula…
Leggi
A phase 2 randomized trial of survodutide in MASH and fibrosis
Sanyal AJ, Bedossa P, Fraessdorf M, et al.
N Engl J Med. Pub. online 7 Jun 2024.
Leggi
Identifying subtypes of type 2 diabetes mellitus with machine learning: development, internal validation, prognostic validation and medication burden in linked electronic health records in 420 448 individuals
Mizani MA, Dashtban A, Pasea L, et al.
BMJ Open Diabetes Res Care. Pub. online 4 Jun 2024.
Leggi
Reducing cardiometabolic risk with semaglutide in type 1 diabetes (RESET1): study protocol of a phase 2 double-blinded randomised placebo-controlled trial
Frampton R, Snaith JR, Hocking S, et al.
Diabet Med. Pub. online 9 Jun 2024.
Leggi
Glucagon agonism in the treatment of metabolic diseases including type 2 diabetes mellitus and obesity
Winther JB, Holst JJ
Diabetes Obes Metab. Pub. online 9 Jun 2024.
Leggi
Utilizing synchronous care to improve cardiovascular and renal health among patients with type 2 diabetes: proof-of-concept results from the DECIDE-CV clinical programme
Marques P, Mavrakanas TA, Guida J, et al.
Diabetes Obes Metab. Pub. online 3 Jun 2024.
Leggi